Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Phenylpropanolamine patch

Executive Summary

Lewisville, Texas-based Bio-American's ANDA suitability petition for a 150 mg phenylpropanolamine patch for weight loss denied by FDA Oct. 7. Noting that phenylpropanolamine is not generally recognized as safe and effective for weight loss, the agency explained that ANDA petition route cannot be used unless the final monograph on OTC weight loss products, which has not yet been issued, recognizes the 150 mg strength of the ingredient. Weight loss panel recommended that only a 75 mg strength be listed as safe and effective for weight loss.

Lewisville, Texas-based Bio-American's ANDA suitability petition for a 150 mg phenylpropanolamine patch for weight loss denied by FDA Oct. 7. Noting that phenylpropanolamine is not generally recognized as safe and effective for weight loss, the agency explained that ANDA petition route cannot be used unless the final monograph on OTC weight loss products, which has not yet been issued, recognizes the 150 mg strength of the ingredient. Weight loss panel recommended that only a 75 mg strength be listed as safe and effective for weight loss.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS014455

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel